Pharma & Life Sciences

American Society of Gene and Cell Therapy Policy Summit (ASGCT Policy Summit)

The 9th Gene Therapy Development Summit is a two-day event focused on advancing gene therapies for rare and common diseases. It brings together experts in pre-clinical development, manufacturing, analytical development, clinical operations, and regulatory affairs. The summit is designed for professionals involved in the gene therapy development process.

Official websiteRegister
6 weeks until it opens.

The essentials

Event details

Dates
14 September 2026
Location
Washington DC, United States
Organiser
9th Gene Therapy Development Summit 2026
Expected attendance
21
Industry
Pharma & Life Sciences

Agenda themes

Topics covered

  • Cell therapy
  • Gene therapy
  • Science & Research
  • Medical & Pharma

On stage

Speakers

  • Damir Simic, Executive Director, Astellas Pharma
  • Jorge Santiago-Ortiz, Senior Director - Chemistry, Manufacturing & Controls, Apertura
  • Devyn Smith, Chief Executive Officer, Arbor Biotechnologies, Inc
  • Hebe Sun, Associate Director, CDx/IVD Regulatory Affairs, Regeneron Pharmaceuticals
  • Tassos Georgiadis, Senior VP, Discovery & Preclinical Development, MeiraGTx
  • Casey Maguire, Investigator & Associate Professor, Harvard Medical School
  • Lindsay Marjoram, CSO, Barth Syndrome Foundation Inc

On the floor

Sponsors and partners

  • Bayer
  • Astellas Pharmaceuticals
  • REGENXBIO
  • Ocugen
  • AskBio

Logistics

Where to stay

Places to stay near the venue.

Keep planning

Related events

Spot something wrong on this page? Report a correction and we will fix it.